Amphastar Pharmaceuticals, Inc.
(NASDAQ : AMPH)

( )
AMPH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corp. Plc
0.58%22.731.7%$274.90m
VRXValeant Pharmaceuticals International, Inc.
-0.67%28.2114.1%$165.99m
MDCOThe Medicines Co.
19.71%70.2120.2%$158.44m
BHCBausch Health Cos., Inc.
-0.67%28.210.0%$114.50m
GWPHGW Pharmaceuticals Plc
1.06%103.566.2%$82.41m
JAZZJazz Pharmaceuticals Plc
0.20%138.902.3%$66.29m
SAGESAGE Therapeutics, Inc.
1.37%147.968.6%$54.40m
PRGOPerrigo Co. Plc
-0.47%48.746.8%$52.31m
UTHRUnited Therapeutics Corp.
2.05%92.5214.3%$41.02m
ICPTIntercept Pharmaceuticals, Inc.
3.07%85.5516.9%$40.51m
ICLRICON plc
0.92%155.434.2%$38.60m
HZNPHorizon Therapeutics Plc
-0.73%30.506.6%$38.47m
ENDPEndo International Plc
-0.11%4.458.8%$36.59m
CTLTCatalent, Inc.
1.39%51.122.4%$31.86m
ARGXargenx SE
3.63%146.630.0%$28.80m

Company Profile

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.